Skip to content
The Nexus
DossierENTITY

pegcetacoplan

Coverage of pegcetacoplan in the Nexus archive.

Earliest in view: Jul 18 · 19:45 UTCMost recent: Jul 18 · 19:45 UTC
Co-mentioned in this coverage
Syfovretopic1geographic atrophytopic1neovascular age-related macular degenerationtopic1MedPage Todayorganization1Montrealplace1complement inhibitortopic1
Recent coverage
  • HEALTHJul 18 · 19:45 UTCMEDPAGE TODAY
    Vision Benefits in GA With Complement Inhibitor, Regardless of AMD, Anti-VEGF

    Pegcetacoplan (Syfovre), a complement inhibitor, showed similar efficacy in treating geographic atrophy (GA) whether administered to patients with concurrent neovascular age-related macular degeneration (nAMD) or to those with GA alone. The findings are based on data from a retina clinical trial.

pegcetacoplan · Dossier · The Nexus